Clinical trial
ORBERA™ Post-Approval Study
NCT02828657 is registered in ClinicalTrials.gov with Apollo Endosurgery, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- ORBERA™ Post-Approval Study
- Lead sponsor
- Apollo Endosurgery, Inc.
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 30, 2016
- Completion date
- December 31, 2019
- Enrollment
- 284 (actual)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.